MYC and B-cell non-Hodgkin lymphoma: Moreover, recently a ‘mutual negative feedback loop’ involving MYC and miR-548m was described in non-Hodgkin B-cell lymphomas, in that this regulatory loop is important for sustaining a high level of MYC and low level of miR-548m during lymphomagenesis and drug resistance [34].